CN1561768A - 改善睡眠的功能性晚安奶 - Google Patents
改善睡眠的功能性晚安奶 Download PDFInfo
- Publication number
- CN1561768A CN1561768A CN 200410030884 CN200410030884A CN1561768A CN 1561768 A CN1561768 A CN 1561768A CN 200410030884 CN200410030884 CN 200410030884 CN 200410030884 A CN200410030884 A CN 200410030884A CN 1561768 A CN1561768 A CN 1561768A
- Authority
- CN
- China
- Prior art keywords
- milk
- magnesium
- calcium
- tryptophan
- sleep
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000007958 sleep Effects 0.000 title claims abstract description 25
- 235000013336 milk Nutrition 0.000 title claims description 37
- 210000004080 milk Anatomy 0.000 title claims description 37
- 239000008267 milk Substances 0.000 title claims description 37
- 229910052791 calcium Inorganic materials 0.000 claims abstract description 12
- 229910052749 magnesium Inorganic materials 0.000 claims abstract description 7
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims description 18
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 claims description 15
- 239000011575 calcium Substances 0.000 claims description 14
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 claims description 13
- 229960004799 tryptophan Drugs 0.000 claims description 12
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 11
- 239000011777 magnesium Substances 0.000 claims description 9
- 229960003080 taurine Drugs 0.000 claims description 9
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 6
- 229940091250 magnesium supplement Drugs 0.000 claims description 6
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims description 4
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 claims description 4
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 claims description 3
- 239000001095 magnesium carbonate Substances 0.000 claims description 3
- 229910000021 magnesium carbonate Inorganic materials 0.000 claims description 3
- 239000000843 powder Substances 0.000 claims description 3
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 claims description 2
- 229930182827 D-tryptophan Natural products 0.000 claims description 2
- QIVBCDIJIAJPQS-SECBINFHSA-N D-tryptophane Chemical compound C1=CC=C2C(C[C@@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-SECBINFHSA-N 0.000 claims description 2
- 108010082495 Dietary Plant Proteins Proteins 0.000 claims description 2
- 108010046377 Whey Proteins Proteins 0.000 claims description 2
- 102000007544 Whey Proteins Human genes 0.000 claims description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 claims description 2
- 229960003563 calcium carbonate Drugs 0.000 claims description 2
- 235000010216 calcium carbonate Nutrition 0.000 claims description 2
- 229940092124 calcium citrate malate Drugs 0.000 claims description 2
- 239000001506 calcium phosphate Substances 0.000 claims description 2
- MPCMQXRREZMSPJ-UHFFFAOYSA-L calcium;2-hydroxybutanedioate;2-hydroxypropane-1,2,3-tricarboxylic acid;pentahydrate Chemical compound O.O.O.O.O.[Ca+2].[O-]C(=O)C(O)CC([O-])=O.OC(=O)CC(O)(C(O)=O)CC(O)=O MPCMQXRREZMSPJ-UHFFFAOYSA-L 0.000 claims description 2
- 239000012141 concentrate Substances 0.000 claims description 2
- 230000006872 improvement Effects 0.000 claims description 2
- 229960001708 magnesium carbonate Drugs 0.000 claims description 2
- 235000014380 magnesium carbonate Nutrition 0.000 claims description 2
- 229960005336 magnesium citrate Drugs 0.000 claims description 2
- 239000004337 magnesium citrate Substances 0.000 claims description 2
- 235000002538 magnesium citrate Nutrition 0.000 claims description 2
- 239000001755 magnesium gluconate Substances 0.000 claims description 2
- 229960003035 magnesium gluconate Drugs 0.000 claims description 2
- 235000015778 magnesium gluconate Nutrition 0.000 claims description 2
- OVGXLJDWSLQDRT-UHFFFAOYSA-L magnesium lactate Chemical compound [Mg+2].CC(O)C([O-])=O.CC(O)C([O-])=O OVGXLJDWSLQDRT-UHFFFAOYSA-L 0.000 claims description 2
- 239000000626 magnesium lactate Substances 0.000 claims description 2
- 229960004658 magnesium lactate Drugs 0.000 claims description 2
- 235000015229 magnesium lactate Nutrition 0.000 claims description 2
- 229910052943 magnesium sulfate Inorganic materials 0.000 claims description 2
- 229960003390 magnesium sulfate Drugs 0.000 claims description 2
- 235000019341 magnesium sulphate Nutrition 0.000 claims description 2
- IAKLPCRFBAZVRW-XRDLMGPZSA-L magnesium;(2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanoate;hydrate Chemical compound O.[Mg+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O IAKLPCRFBAZVRW-XRDLMGPZSA-L 0.000 claims description 2
- YZURQOBSFRVSEB-UHFFFAOYSA-L magnesium;2-aminoethanesulfonate Chemical compound [Mg+2].NCCS([O-])(=O)=O.NCCS([O-])(=O)=O YZURQOBSFRVSEB-UHFFFAOYSA-L 0.000 claims description 2
- 239000000203 mixture Substances 0.000 claims description 2
- IFGCUJZIWBUILZ-UHFFFAOYSA-N sodium 2-[[2-[[hydroxy-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyphosphoryl]amino]-4-methylpentanoyl]amino]-3-(1H-indol-3-yl)propanoic acid Chemical compound [Na+].C=1NC2=CC=CC=C2C=1CC(C(O)=O)NC(=O)C(CC(C)C)NP(O)(=O)OC1OC(C)C(O)C(O)C1O IFGCUJZIWBUILZ-UHFFFAOYSA-N 0.000 claims description 2
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 claims description 2
- 229940078499 tricalcium phosphate Drugs 0.000 claims description 2
- 229910000391 tricalcium phosphate Inorganic materials 0.000 claims description 2
- 235000019731 tricalcium phosphate Nutrition 0.000 claims description 2
- PLSARIKBYIPYPF-UHFFFAOYSA-H trimagnesium dicitrate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O PLSARIKBYIPYPF-UHFFFAOYSA-H 0.000 claims description 2
- 235000021119 whey protein Nutrition 0.000 claims description 2
- 235000020604 functional milk Nutrition 0.000 abstract 1
- 235000013365 dairy product Nutrition 0.000 description 4
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 206010022437 insomnia Diseases 0.000 description 3
- 238000011835 investigation Methods 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 230000035764 nutrition Effects 0.000 description 3
- 239000003381 stabilizer Substances 0.000 description 3
- 239000006035 Tryptophane Substances 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 235000020247 cow milk Nutrition 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 208000019116 sleep disease Diseases 0.000 description 2
- 208000020685 sleep-wake disease Diseases 0.000 description 2
- 206010054196 Affect lability Diseases 0.000 description 1
- 241001116389 Aloe Species 0.000 description 1
- 208000019914 Mental Fatigue Diseases 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 235000011399 aloe vera Nutrition 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 210000004958 brain cell Anatomy 0.000 description 1
- 235000021152 breakfast Nutrition 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 235000021277 colostrum Nutrition 0.000 description 1
- 210000003022 colostrum Anatomy 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000007830 nerve conduction Effects 0.000 description 1
- 235000021049 nutrient content Nutrition 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000002787 reinforcement Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
本发明公开了改善睡眠的功能性晚安奶，特征就在于使每公斤成品牛奶含有以下成分：色氨酸(Try)400～2000mg；钙(Ca)1200～2500mg；镁(Mg)500～1200mg；牛磺酸(Tau)200～1000mg。本发明的优点在于：创造性的使牛奶细分，赋予牛奶显著改善睡眠的功能，并同时补充多种营养。
Description
发明领域
本发明属于食品技术领域，更具体的涉及一种乳制品，特别是一种改善睡眠的功能性晚安奶。
背景技术
在这个世界上，每个人都盼望着每晚有个美妙甜蜜的睡眠。长期睡眠不足将会导致人体内各系统严重受损，影响人们的工作生活和健康。资料表明，在我国现在大约有10％以上的人存在着不同程度的睡眠障碍，主要的症状有失眠、睡眠时间颠倒等。其中，以失眠最为常见。此外，临床调查也显示，近几年，我国患睡眠障碍的病人在门诊中呈快速增长趋势，其中不少是中青年人。调查还表明，我国35岁以下的成年人有40％以上的人有过失眠经历。这主要和生活节奏太快、生活压力加大以及饮酒等不良生活习惯有关。由此，镇静剂和抗忧郁剂销量大增，但随后出现的也就是人们如今已看到的，对这些药物的依赖性和嗜药性等问题。
据资料介绍，牛奶有催眠作用，在睡觉前喝牛奶最好，尤其是对一些夜间难以入睡的老年人，睡前一杯奶，可以促进睡眠。这是因为牛奶中含有α-乳白蛋白，α-乳白蛋白是自然界中所有蛋白中色氨酸含量最高的，然而就是它，使牛奶具有了帮助睡眠的作用。它的科学机理在于：α-乳白蛋白促进了色氨酸和松果体素的合成，从而调节大脑神经，能消除脑细胞紧张状态、使大脑轻松，改善睡眠。但问题是普通牛奶中的α-乳白蛋白和色氨酸的含量是很有限的。
目前国内乳业同质化现象严重，各路乳业巨头的竞争日趋激烈。只有运用“产品差异化”原则的企业才能够获得竞争优势。纵观当前乳品行业，市场细分策略体现得淋漓尽致，早餐奶、牛初乳、免疫奶、营养强化奶、芦荟奶(目前仍存有争议)、纯鲜奶、特浓奶等等数不胜数。一般认为牛奶最好是在傍晚或临睡之前半小时饮用，据本发明人调查，目前市场上尚没有改善睡眠的功能性晚安奶的生产和销售，经科技和专利文献检索，也未见有关改善睡眠的功能性晚安奶的研制与开发。改善睡眠的功能性晚安奶正是典型液态奶市场被细分后的一种必然结果。
发明内容
本发明的目的在于提供一种有利于改善睡眠的功能性晚安奶。为了解决上述问题，本发明人进行了深入研究发现，通过使用特定的和特定量的营养强化剂，可以制得稳定性和口感等都比较满意的液体牛奶，不仅提高了牛奶体系营养素含量，更是赋予产品优良的改善睡眠功能，最终完成了本发明。本发明的内容特征就在于使每公斤成品牛奶含有以下成分：色氨酸(Try)400～2000mg；钙(Ca)1200～2500mg；镁(Mg)500～1200mg；牛磺酸(Tau)200～1000mg。
本发明选用的特定的营养强化剂，其中色氨酸是指L-色氨酸、D-色氨酸、DL-色氨酸、α-乳白蛋白、富含α-乳白蛋白的乳清蛋白浓缩物、富含α-乳白蛋白的植物蛋白提取物的至少一种或几种；钙源为牡蛎粉、珍珠粉、碳酸钙、磷酸三钙、柠檬酸苹果酸钙、乳钙素的至少一种或几种；镁源为碳酸镁、硫酸镁、乳酸镁、柠檬酸镁、葡萄糖酸镁的至少一种或几种；牛磺酸为牛磺酸、牛磺酸钙、牛磺酸镁的至少一种或几种。
本发明提供的一种改善睡眠的功能性晚安奶的优点在于：创造性的使牛奶细分，赋予牛奶显著改善睡眠的功能，并同时补充多种营养。这是因为牛奶虽然被认为是一种比较理想的助眠食品，但其中的色氨酸含量较低，仅为34～44mg/100g。色氨酸的催眠作用已经被很好的研究，并遵循具有约1000mg的坪值的平稳剂量反应曲线。研究表明：在单独服用时，一般250mg的色氨酸就足以改善患有轻度失眠症病人的睡眠，而且无任何不良的副作用。现代人最缺乏的被认为是钙。如果钙不足，除了会引起骨质疏松等以外，也会造成人常处于焦躁不安的状态，钙对神经传导也有很大影响，它有缓和神经兴奋和紧张的功能。由于镁元素的不足而引起钙在细胞内增加，更会引起精神较早和情绪不稳，钙和镁被统称为“抗精神疲劳的矿物质”。牛磺酸同样具有解热镇痛，镇静安神的功能。四者配伍有促进强化的作用，能显著改善人体的睡眠。
具体实施
产品配方(以1吨牛奶计)
原料 用量(Kg) 备注
生鲜牛乳 987.00 脂肪≥3.20％，乳固体≥12.0％
水 10.00 用于溶解稳定剂和营养强化剂
珍珠粉 1.00 使成品牛奶1000g含Ca 1400mg
碳酸镁 1.00 使成品牛奶1000g含Mg 600mg
L-色氨酸 0.40 使成品牛奶1000g含色氨酸800mg
牛磺酸 0.40 使成品牛奶1000g含牛磺酸400mg
稳定剂 0.20 最好用高钙奶稳定剂
生产工艺流程：生鲜牛乳→标准化→加稳定剂→加营养强化剂→均质(60℃，15～18MPa)→杀菌→冷却→罐装→检测→成品
所述实施例只是对本发明的进一步说明，不应理解为是对本发明的限制。
Claims (2)
1改善睡眠的功能性晚安奶，其特征就在于使每公斤成品牛奶含有以下成分：
色氨酸(Try) 400～2000mg；
钙(Ca) 1200～2500mg；
镁(Mg) 500～1200mg；
牛磺酸(Tau) 200～1000mg。
2根据权利要求1所述的改善睡眠的功能性晚安奶，其特征在于选用的色氨酸是指L-色氨酸、D-色氨酸、DL-色氨酸、α-乳白蛋白、富含α-乳白蛋白的乳清蛋白浓缩物、富含α-乳白蛋白的植物蛋白提取物的至少一种或几种；钙源为牡蛎粉、珍珠粉、碳酸钙、磷酸三钙、柠檬酸苹果酸钙、乳钙素的至少一种或几种；镁源为碳酸镁、硫酸镁、乳酸镁、柠檬酸镁、葡萄糖酸镁的至少一种或几种；牛磺酸为牛磺酸、牛磺酸钙、牛磺酸镁的至少一种或几种。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200410030884 CN1277480C (zh) | 2004-04-09 | 2004-04-09 | 改善睡眠的功能性晚安奶 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200410030884 CN1277480C (zh) | 2004-04-09 | 2004-04-09 | 改善睡眠的功能性晚安奶 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1561768A true CN1561768A (zh) | 2005-01-12 |
| CN1277480C CN1277480C (zh) | 2006-10-04 |
Family
ID=34481205
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 200410030884 Expired - Fee Related CN1277480C (zh) | 2004-04-09 | 2004-04-09 | 改善睡眠的功能性晚安奶 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1277480C (zh) |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102388974A (zh) * | 2011-11-14 | 2012-03-28 | 江苏星驰生物科技有限公司 | 一种牛初乳配方粉 |
| CN103027116A (zh) * | 2012-12-04 | 2013-04-10 | 内蒙古伊利实业集团股份有限公司 | 一种有助于睡眠的奶粉及其制备方法 |
| CN103349125A (zh) * | 2013-07-22 | 2013-10-16 | 北京绿源求证科技发展有限责任公司 | 一种改善睡眠的食品养生茶冲剂 |
| CN103609944A (zh) * | 2013-12-10 | 2014-03-05 | 南通励成生物工程有限公司 | 降血压助眠的保健食品 |
| CN105325556A (zh) * | 2015-10-29 | 2016-02-17 | 北京银河美科技有限公司 | 一种含热敏感α-乳白蛋白的液态乳制品及制备方法 |
| CN106723021A (zh) * | 2016-11-28 | 2017-05-31 | 武汉哈福科技有限公司 | 一种改善睡眠的功能性食品 |
| CN111960972A (zh) * | 2020-08-28 | 2020-11-20 | 许昌远志生物科技有限公司 | 牛磺酸镁盐及牛磺酸镁配合物的制备工艺与应用 |
-
2004
- 2004-04-09 CN CN 200410030884 patent/CN1277480C/zh not_active Expired - Fee Related
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102388974A (zh) * | 2011-11-14 | 2012-03-28 | 江苏星驰生物科技有限公司 | 一种牛初乳配方粉 |
| CN103027116A (zh) * | 2012-12-04 | 2013-04-10 | 内蒙古伊利实业集团股份有限公司 | 一种有助于睡眠的奶粉及其制备方法 |
| CN103349125A (zh) * | 2013-07-22 | 2013-10-16 | 北京绿源求证科技发展有限责任公司 | 一种改善睡眠的食品养生茶冲剂 |
| CN103609944A (zh) * | 2013-12-10 | 2014-03-05 | 南通励成生物工程有限公司 | 降血压助眠的保健食品 |
| CN103609944B (zh) * | 2013-12-10 | 2015-05-13 | 南通励成生物工程有限公司 | 降血压助眠的保健食品 |
| CN105325556A (zh) * | 2015-10-29 | 2016-02-17 | 北京银河美科技有限公司 | 一种含热敏感α-乳白蛋白的液态乳制品及制备方法 |
| CN106723021A (zh) * | 2016-11-28 | 2017-05-31 | 武汉哈福科技有限公司 | 一种改善睡眠的功能性食品 |
| CN111960972A (zh) * | 2020-08-28 | 2020-11-20 | 许昌远志生物科技有限公司 | 牛磺酸镁盐及牛磺酸镁配合物的制备工艺与应用 |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1277480C (zh) | 2006-10-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Jäger et al. | International society of sports nutrition position stand: protein and exercise | |
| ES2269514T3 (es) | Compuesto nutritivo para tratar afecciones inmunologicas. | |
| Singh et al. | Manufacturing jaggery, a product of sugarcane, as health food | |
| CN100391353C (zh) | 新生婴儿配方奶粉 | |
| CN101268835B (zh) | 一种儿童型营养高钙冲剂及其生产制作工艺 | |
| JPH0649647B2 (ja) | 人間の第４期睡眠増強剤 | |
| US20210360958A1 (en) | Sleep-improving compositions | |
| EP1351584A2 (en) | Nutritional composition for a bone condition | |
| Jain et al. | Development of low cost nutritional beverage from whey | |
| CN102356877A (zh) | Cbp养钙冲剂 | |
| PT102430A (pt) | Metodo aditivo de producao de agua potavel e de bebidas padronizadas a partir de agua (destilada ou desmineralizada) e de bebidas, para perfis de saude | |
| CN1277480C (zh) | 改善睡眠的功能性晚安奶 | |
| EA016259B1 (ru) | Применение кальций-пептидного компонента для снижения веса тела | |
| US20090324733A1 (en) | Composition of Whey Growth Factor Extract for Reducing Muscle Inflammation | |
| JP2016506753A (ja) | 食品組成物及びその使用 | |
| JPH09296198A (ja) | コレステロール強化油脂およびその調製方法 | |
| CN107183670B (zh) | 一种增免儿童青少年型多矿多维制剂及其制备方法 | |
| CN1692783A (zh) | 阿胶奶及其制备工艺 | |
| CN108576252A (zh) | 一种复合多肽蛋白粉固体饮料及其生产工艺 | |
| RU2182794C2 (ru) | Молочный напиток для геродиетического питания | |
| CN104782775A (zh) | 一种百香果味水牛奶制品 | |
| Kumari et al. | Influence of dietary molecules on human health: Whey proteins | |
| CN101700066B (zh) | 一种促进幼儿脑发育的维生素饮料的制备方法 | |
| WO2019113735A1 (zh) | 一种长保质期原味含乳饮料及其制备方法 | |
| FI120720B (fi) | Maitopohjaisia elintarvikkeita, jotka sisältävät keskushermoston lipidejä |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: HULUNBEIR HAIRU YIWEI TECHNOLOGY AND TRADE CO., LT Free format text: FORMER OWNER: LI WEIPING Effective date: 20100402 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 050031 MAILBOX 5158, ZHAIYING POST OFFICE, SHIJIAZHUANG CITY, HEBEI PROVINCE TO: 021008 NO.76, JIAGEDAQI ROAD, HAILAR DISTRICT, HULUNBEIER CITY, INNER MONGOLIA AUTONOMOUS REGION |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20100402 Address after: 021008 No. 76, Jiagedaqi Road, Hailar District, the Inner Mongolia Autonomous Region, Hulun Buir Patentee after: Hulun Buir sea itvid dairy trade Co.,Ltd. Address before: 5158 mailbox, Zhai Ying post office, Shijiazhuang, Hebei, 050031 Patentee before: Li Weiping |
|
| DD01 | Delivery of document by public notice |
Addressee: Li Weiping Document name: Notification of Passing Examination on Formalities |
|
| ASS | Succession or assignment of patent right |
Owner name: HULUNBUIR HAIRU DAIRY PRODUCTS CO., LTD. Free format text: FORMER OWNER: HULUNBUIR HAIRU YIWEI TECHNOLOGY + TRADE CO., LTD. Effective date: 20110727 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20110727 Address after: 021008, the Inner Mongolia Autonomous Region, Hulun Buir Hailar District, 301 National Road South (Hulun Buir Economic Development Zone) Patentee after: HULUNBEIER HAIRU DAIRY INDUSTRY CO.,LTD. Address before: 021008 No. 76, Jiagedaqi Road, Hailar District, the Inner Mongolia Autonomous Region, Hulun Buir Patentee before: Hulun Buir sea itvid dairy trade Co.,Ltd. |
|
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20061004 |